V Square Quantitative Management LLC Purchases 177 Shares of Encompass Health Co. (NYSE:EHC)

V Square Quantitative Management LLC increased its position in Encompass Health Co. (NYSE:EHC) by 43.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 581 shares of the company’s stock after purchasing an additional 177 shares during the quarter. V Square Quantitative Management LLC’s holdings in Encompass Health were worth $54,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Vontobel Holding Ltd. grew its stake in Encompass Health by 216.6% in the 4th quarter. Vontobel Holding Ltd. now owns 24,508 shares of the company’s stock valued at $2,263,000 after buying an additional 16,768 shares during the last quarter. Lightrock Netherlands B.V. acquired a new position in Encompass Health in the 4th quarter valued at about $7,196,000. Apollon Wealth Management LLC grew its stake in Encompass Health by 7.3% in the 4th quarter. Apollon Wealth Management LLC now owns 2,856 shares of the company’s stock valued at $264,000 after buying an additional 194 shares during the last quarter. Lecap Asset Management Ltd. acquired a new position in Encompass Health in the 4th quarter valued at about $1,314,000. Finally, Fairvoy Private Wealth LLC acquired a new position in Encompass Health in the 4th quarter valued at about $208,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analyst Ratings Changes

EHC has been the topic of a number of research reports. KeyCorp upped their price target on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. William Blair restated an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Barclays increased their target price on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. StockNews.com upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Royal Bank of Canada restated an “outperform” rating and set a $110.00 target price on shares of Encompass Health in a research report on Tuesday, February 11th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $107.67.

Insider Activity at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.10% of the stock is owned by insiders.

Encompass Health Stock Performance

NYSE EHC opened at $100.91 on Tuesday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $10.17 billion, a price-to-earnings ratio of 22.62, a P/E/G ratio of 1.18 and a beta of 0.90. The firm’s 50 day simple moving average is $95.95 and its 200 day simple moving average is $95.62. Encompass Health Co. has a 1 year low of $73.02 and a 1 year high of $104.55.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 18.06%. As a group, research analysts expect that Encompass Health Co. will post 4.76 earnings per share for the current fiscal year.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.